Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04184375 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cognitive Stimulation for Elderly Bipolar Patients

Study acronym: TONIC
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 17, 2025 (before its estimated March 3, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Mar 3, 2025 to Mar 3, 2026
    • Study completion date: Sep 3, 2025 to Sep 3, 2026
    v8
  2. Re-verified, no change to tracked fieldsv7
  3. Primary completion date: Dec 15, 2022 to Mar 3, 2025
    • Start date: Sep 10, 2020 to Mar 4, 2021
    • Study completion date: Mar 15, 2023 to Sep 3, 2025
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 1, 2020 to Sep 10, 2020
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jun 15, 2022 to Dec 15, 2022
    • Start date: Mar 1, 2020 to Sep 1, 2020
    • Study completion date: Sep 15, 2022 to Mar 15, 2023
    v3
  2. Start date: Jan 15, 2020 to Mar 1, 2020
    • Primary completion date: Apr 15, 2022 to Jun 15, 2022
    • Study completion date: Jul 15, 2022 to Sep 15, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.
Trial Details
NCT Number NCT04184375
Lead Sponsor Groupe Hospitalier de la Rochelle Ré Aunis
Conditions
(from sponsor)		 Bipolar Disorder, Cognitive Impairment, Age-related Cognitive Decline
Related terms Bipolar Disorder, Cognitive Dysfunction
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov